Kamada Ltd. (KMDA) Earnings Call Analysis

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

23/25

Growth 5 Margin 5 Expansion 5 Platform 3 Financial 5

latest quarter score

Earnings Reports

23
KMDA Q2 2026: 23% Revenue Surge Highlights Robust Organic Growth and Strategic Execution
August 12, 2026
16
Kamada (KMDA) Q1 2026: Plasma Center Revenue Pathway Opens, $8–10M Capacity Per Site Signals Expansion
May 13, 2026
18
Kamada (KMDA) Q4 2025: Dividend Payout Hits $14M as Organic Growth Drives 13% Revenue Guidance Lift
March 11, 2026
17
Kamada (KMDA) Q3 2025: Adjusted EBITDA Climbs 34% as Portfolio Diversifies Beyond Royalties
November 10, 2025
18
Kamada (KMDA) Q2 2025: EBITDA Margin Hits 25% as Portfolio Diversification Drives Profitable Growth
August 13, 2025
23
Kamada (KMDA) Q1 2025: EBITDA Jumps 54% as Portfolio Diversity Fuels Profitable Growth
July 03, 2025
Kamada Ltd. (KMDA) Q4 2024: Record Revenue Growth Supports $0.20 Special Dividend and Expands Plasma Collection Capacity
March 05, 2025

Browse all companies